CONVERTIBLE NOTE DUE APRIL ___, 2018Intellect Neurosciences, Inc. • April 28th, 2016 • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of INTELLECT NEUROSCIENCES, INC., a Delaware corporation, (the “Borrower”), having its principal place of business at 550 Sylvan Avenue, Suite 101, Englewood Cliffs, NJ 07632, facsimile: (201) 608-5103, due April ___, 2018 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 28th, 2016 • Intellect Neurosciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April __, 2016, between Intellect Neurosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
INTERCREDITOR AND SUBORDINATION AGREEMENTIntercreditor and Subordination Agreement • April 28th, 2016 • Intellect Neurosciences, Inc. • Pharmaceutical preparations • New York
THIS INTERCREDITOR AND SUBORDINATION AGREEMENT, dated as of April __, 2016, (this “Agreement”), is by and among Intellect Neurosciences, Inc., a Delaware corporation (the “Company”), the parties identified on Schedule A hereto (“Senior Lenders”) and the parties identified on Schedule B hereto (the “Junior Lenders” and together with Company and Senior Lenders each a “Party” and collectively the “Parties”).
